News for 'FDA India'

US Senator warns against poor-quality drugs from India

US Senator warns against poor-quality drugs from India

Rediff.com17 Oct 2025

United States Senator Jim Banks has urged the Food and Drug Administration (FDA) to step up inspections of overseas pharmaceutical manufacturing facilities, expressing concern over poor-quality drugs being imported from countries like India and China.

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Rediff.com17 Feb 2026

'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.

Aamir Khan Moves In With Gauri Spratt

Aamir Khan Moves In With Gauri Spratt

Rediff.com22 Jan 2026

Aamir Khan on Gauri Spratt: 'In my heart, I'm already married to her'

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Sena MLA booked for slapping canteen worker, threatens MIM leader

Sena MLA booked for slapping canteen worker, threatens MIM leader

Rediff.com12 Jul 2025

A non-cognisable offence is being filed against Shiv Sena MLA Sanjay Gaikwad in connection with the assault of a canteen worker at the MLA hostel. The incident sparked outrage after a video surfaced showing Gaikwad assaulting the worker over allegedly stale food.

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com5 Jun 2025

'We recently launched Yesintek in the immunology space.'

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Who Is Gauri Spratt, Aamir's Latest Love?

Who Is Gauri Spratt, Aamir's Latest Love?

Rediff.com14 Mar 2025

Her grandfather Philip Spratt was accused by the British Raj in the Meerut Conspiracy Case in the late 1920s. Meet the lady in Aamir Khan's life.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Why US FDA is cracking down on India's shrimp shipments

Why US FDA is cracking down on India's shrimp shipments

Rediff.com12 Feb 2019

US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

Rediff.com17 Mar 2016

It is one of 42 drug-making factories in India that the FDA has banned in recent years

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

It's confirmed! McDonald's India uses authentic cheese

It's confirmed! McDonald's India uses authentic cheese

Rediff.com5 Mar 2024

Westlife Foodworld, fast-food chain McDonald's operator in West and South India, on Tuesday said food safety regulator FSSAI has verified the cheese used by it and is now allowed to use the word cheese in the name of its products. Additionally, an independent NABL (National Accreditation Board for Testing and Calibration Laboratories) has also confirmed that Westlife Foodworld uses authentic cheese in its food preparation and not cheese analogues or substitutes, its managing director Saurabh Kalra said.

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Rediff.com29 Jul 2015

Maharashtra's Food and Drugs Administration on Wednesday argued in the Bombay High Court that Nestle India.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Pharma cos should learn to appreciate FDA norms: Experts

Pharma cos should learn to appreciate FDA norms: Experts

Rediff.com23 Nov 2014

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Standards violation: FDA seizes Caraco drugs

Standards violation: FDA seizes Caraco drugs

Rediff.com26 Jun 2009

The US Food and Drug Administration has seized drug products manufactured by Caraco Pharmaceutical, at the company's Michigan facilities in Detroit, Farmington Hills, and Wixom, the US FDA said on Thursday. The FDA seeks to immediately stop Caraco from further distributing drugs until there is assurance that the firm complies with good manufacturing requirements, it added.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

Now, UP FDA finds lead in ITC's Yippee noodles

Now, UP FDA finds lead in ITC's Yippee noodles

Rediff.com24 Aug 2015

Uttar Pradesh Food and Drug Authority (FDA) says it has found excess lead in the Yippee noodles of domestic giant ITC.

FDA asks Wockhardt to conduct global assessment of its plants

FDA asks Wockhardt to conduct global assessment of its plants

Rediff.com4 Dec 2013

The FDA Commissioner Margaret Hamburg is slated to travel to India soon.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

India's Jaden selected for Ferrari Driver Academy trials

India's Jaden selected for Ferrari Driver Academy trials

Rediff.com16 Aug 2023

Rising Indian driver Jaden R Pariat has been invited to the Ferrari Driver Academy (FDA) selection trials.

Why Is USFDA Inspecting India Pharma Firms?

Why Is USFDA Inspecting India Pharma Firms?

Rediff.com30 Dec 2022

Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.

US FDA to set up Indian offices by '09

US FDA to set up Indian offices by '09

Rediff.com21 Jul 2008

Under fire from some United States senators for allegedly taking lenient positions in granting product approvals to generic companies from countries like India, the US FDA is planning to speed up its plans to set up offices in India by 2009. FDA, in its latest newsletter dated July 21, has said that the agency will set up offices in Mumbai and Delhi to intensify its monitoring efforts.

Now, US FDA gets a call from Indian pharma companies

Now, US FDA gets a call from Indian pharma companies

Rediff.com27 Oct 2013

The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Wockhardt hit by FDA alert on another plant

Wockhardt hit by FDA alert on another plant

Rediff.com27 Nov 2013

Its factory in Chikalthana in western India was last month hit by the British drug regulator's curb on imports from the plant over manufacturing deficiencies.

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Rediff.com10 Jun 2013

Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.

India to have US FDA-like drug regulator

India to have US FDA-like drug regulator

Rediff.com23 Jun 2005

To be called Central Drug Administration or National Drug Authority, it will have 10 sub-authorities to deal with areas like cosmetics, blood safety, medical equipment, etc.